Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: A review of the literature with epidemiological and economic modelling

Health Technology Assessment

Volumn 7, Issue 39, 2003, Pages

  Cooper, B S ^a   Stone, S P ^a   Kibbler, C C ^a   Cookson, B D ^b,c   Roberts, J A ^c   Medley, G F ^d   Duckworth, G J ^b   Lai, R ^a   Ebrahim, S ^e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACITRACIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CHLORHEXIDINE; FUSIDATE SODIUM; FUSIDIC ACID; GENTAMICIN; GLYCOPEPTIDE; LINEZOLID; METICILLIN; NEOMYCIN; PENICILLIN G; POVIDONE IODINE; PSEUDOMONIC ACID; RIFAMPICIN; STREPTOMYCIN; SULFAMETHOXAZOLE; TEICOPLANIN; TETRACYCLINE; TRICLOSAN; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; EMBASE; EPIDEMIOLOGICAL DATA; ERADICATION THERAPY; HEALTH CARE POLICY; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; MEDLINE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OUTCOMES RESEARCH; PATIENT CARE; REVIEW; SCREENING; STAPHYLOCOCCUS INFECTION; STATISTICAL ANALYSIS; STATISTICAL MODEL; STOCHASTIC MODEL; WARD; COST BENEFIT ANALYSIS; CROSS INFECTION; ECONOMICS; HEALTH SERVICES RESEARCH; HOSPITAL MANAGEMENT; OUTCOME ASSESSMENT; PENICILLIN RESISTANCE; POLICY; STANDARD; STAPHYLOCOCCUS AUREUS; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; CROSS INFECTION; GREAT BRITAIN; HEALTH SERVICES RESEARCH; HOSPITAL ADMINISTRATION; HUMANS; METHICILLIN RESISTANCE; MODELS, ECONOMETRIC; ORGANIZATIONAL POLICY; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ISOLATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 85044706288     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta7390     Document Type: Review

References (320)

1. Reacher MH, Shah A, Livermore DM, Wale MC, Graham C, Johnson AP, et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: Trend analysis. BMJ 2000;320:213-16.
2. Staphylococcus aureus bacteraemia: England and Wales January to December 2000. Communicable Disease Report. CDR Wkly 15 February 2001; 11:7. Available at http:/www.hpa.org.uk/cdr/PDFfiles/2001/cdr0701.pdf
3. First report of the Department of Health's mandatory MRSA bacteraemia surveillance scheme in acute NHS Trusts in England: April to September 2001. CDR Wkly 7 February 2002; 12:6 http://www.hpa.org.uk/cdr/PDFfiles/2002/cdr0602.pdf
4. British Society for Antimicrobial Chemotherapy, Hospital Infection Society and the Infection Control Nurses Association. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect 1998;39:253-90.
5. Williams REO. Healthy carriage of Staphylococcus aureus: Its prevalence and importance. Bacteriol Rev 1963;27:56.
6. Lee YL, Cesario T, Pax A, Tran C, Ghouri A, Thrupp LD. Nasal colonization by Staphylococcus aureus in active, independent, community seniors. Age Ageing 1999;28:229-32.
7. Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA, et al. Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94:313-28.
8. Cookson B, Peters B, Webster M, Phillips I, Rahman M, Noble W. Staff carriage of epidemic methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1989;27:1471-6.
9. Rammelkamp CH, Mortimer EA, Wolinsky E. Transmission of streptococcal and staphylococcal infections. Ann Intern Med 1964;60:753-8.
10. Peacock JE, Marsik FJ, Wenzel RP. Methicillin-resistant Staphylococcus aureus: Introduction and spread within a hospital. Ann Intern Med 1980;93:526-32.
11. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982;97:309-17.
12. French GL, Cheng AF, Ling JM, Mo P, Donnan S. Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence. J Hosp Infect 1990;15:117-25.
13. Meers PD, Leong KY. The impact of methicillin- and aminoglycoside-resistant Staphylococcus aureus on the pattern of hospital-acquired infection in an acute hospital. J Hosp Infect 1990;16:231-9.
14. Peacock JE, Moorman DR, Wenzel RP, Mandell GL. Methicillin-resistant Staphylococcus aureus: Microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain. J Infect Dis 1981;144:575-82.
15. Marty L, Flahault A, Suarez B, Caillon J, Hill C, Andremont A. Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients. Intensive Care Med 1993;19:285-9.
16. Cheng AF, French GL. Methicillin-resistant Staphylococcus aureus bacteraemia in Hong Kong. J Hosp Infect 1988;12:91-101.
17. Crossley K, Loesch D, Landsman B. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides 2. Epidemiological studies. J Infect Dis 1979;139:280-7.
18. North EA. Acquired resistance of staphylococci to the action of penicillin. Med J Aust 1946;1:176-9.
19. Barber M, Rozwadowska-Dowzenko M. Infection by penicillin-resistant staphylococci. Lancet 1948;ii:641.
20. Barber M. Staphylococcal infection due to penicillin resistant strains. BMJ 1947;863-72.
21. Bulger R, Sherris JC. Decreased incidence of antibiotic resistance among Staphylococcus aureus: A study in a university hospital over a nine year period. Ann Intern Med 1968;69:1099-108.
22. Knudsen ET, Rolinson GN. Absorption and excretion of a new antibiotic (BRL 1241). BMJ 1960;ii:700.
23. Jevon MP. 'Celbenin' - Resistant staphylococci. BMJ 1961;i:124-5.
24. Rosendal K. Current national patterns. In Proceedings of International Conference on Nosocomial Infections. CDC 1970. Baltimore, MD: Waverly Press; 1971.
25. Benner EJ, Kayser FH. Growing clinical significance of methicillin-resistant Staphylococcus aureus. Lancet 1968;ii:741-4.
26. Parker MT, Hewitt JH. Methicillin resistance in Staphylococcus aureus. Lancet 1970;i:800-4.
27. Shanson DC. Antibiotic-resistant Staphylococcus aureus. J Hosp Infect 1981;2:11-36.
28. Shanson DC, Kensit JC, Duke R. Outbreak of hospital infection with a strain of Staphylococcus aureus resistant to gentamicin and methicillin Lancet 1976;ii:1347-8.
29. Townsend DE, Ashdown N, Bradley JM, Pearman JW, Grubb WB. 'Australian' methicillin-resistant Staphylococcus aureus in a London hospital? Med J Aust 1985;141:339-40.
30. Townsend DE, Ashdown N, Bolton S, Bradley J, Duckworth G, Moorhouse EC, et al. The international spread of methicillin-resistant Staphylococcus aureus. J Hosp Infect 1987;9:60-71.
31. Cox RA, Conquest C, Mallaghan C, Marples RR. A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J Hosp Infect 1995;29:87-106.
32. Kerr S, Kerr GE, Mackintosh CA, Marples RR. A survey of methicillin-resistant Staphylococcus aureus affecting patients in England and Wales. J Hosp Infect 1990;16:35-48.
33. Hiramatsu K, Hanaki H, Ino T. Methicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135-6.
34. Howe RA, Bowker KE, Walsh TR, Feest TG, MacGowan AP. Vancomycin-resistant Staphylococcus aureus. Lancet 1998;351:602.
35. Chien JW, Kucia ML, Salata RA. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant Gram-positive bacterial infections. Clin Infect Dis 2000;30:146-51.
36. Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C, Venkataraman L, et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001;358:207-8.
37. CDC. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortol Wkly Rep 2002;51:565-7.
38. Schentag JJ, Hyatt JM, Carr JR, Paladino JA, Birmingham MC, Zimmer GS, et al. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clin Infect Dis 1998;26:1204-14.
39. Cafferkey MT, Hone R, Coleman D, Pomeroy H, McGrath B, Ruddy R, et al. Methicillin-resistant Staphylococcus aureus in Dublin 1971-84. Lancet 1985;ii:705-8.
40. Hospital Infection Society, British Society for Antimicrobial Chemotherapy. Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. Report of a combined working party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy. J Hosp Infect 1986;7:193-201.
41. Hospital Infection Society, British Society for Antimicrobial Chemotherapy. Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. Report of a combined working party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy. J Hosp Infect 1990;16:351-77.
42. Tarzi S, Kennedy P, Stone S, Evans M. Methicillin resistant Staphylococcus aureus (MRSA): Psychological impact of hospitalisation and isolation in an older adult population. J Hosp Infect 2001;49:250-54.
43. Boyce JM. Nosocomial staphylococcal infections. Ann Intern Med 1981;95:241-2.
44. Stone SP. Managing methicillin-resistant Staphylococcus aureus in hospital: The balance of risk. Age Ageing 1997;26:165-8.
45. Duckworth GJ. Diagnosis and management of methicillin resistant Staphylococcus aureus infection. BMJ 1993;307:1049-52.
46. Cookson BD. Is it time to stop searching for MRSA? BMJ 1997;314:664-5.
47. Teare EL, Barrett SP. Is it time to stop searching for MRSA? Stop the ritual of tracing colonised people. BMJ 1997;314:665-6.
48. Bowler IC, Storr JA. Costs of endemic MRSA. J Hosp Infect 1998;40:159.
49. Cookson BD, Valtz N, Marples R. UK infection control team (ICT) methicillin resistant Staphylococcus aureus (MRSA) questionnaire: Control data. J Hosp Infect 1998; Suppl A:3.1.6.8.
50. Barrett SP, Teare EL, Sage R. Methicillin resistant Staphylococcus aureus in three adjacent health districts of south-east England 1986-91. J Hosp Infect 1993;24:313-25.
51. Cooper BS, Medley GF, Scott GM. Preliminary analysis of the transmission dynamics of nosocomial infections: Stochastic and management effects. J Hosp Infect 1999;43:131-47.
52. Cook TD, Campbell DT. Quasi-experimentation: Design and analysis issues for field settings. Chicago: Rand McNally College Publications; 1979.
53. Grundmann H, Hori S, Winter B, Tami A, Austin DJ. Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: Fitting a model to the data. J Infect Dis 2002;185:481-8.
54. Larson E. A causal link between handwashing and risk of infection? Examination of the evidence. Infect Control 1988;9:28-36.
55. Yoshida J, Kuroki S, Akazawa K, Chijiwa K, Takemori K, Torisu M, et al. The order of ward rounds influences nosocomial infection. A 2-year study in gastroenterologic surgery patients. J Gastroenterol 1995;30:718-24.
56. Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999;28:1062-66.
57. Onesko KM, Wienke EC. The analysis of the impact of a mild, low-iodine, lotion soap on the reduction of nosocomial methicillin-resistant Staphylococcus aureus: A new opportunity for surveillance by objectives. Infect Control 1987;8:255-88.
58. Kibbler CC, Quick A, O'Neill AM. The effect of increased bed numbers on MRSA transmission in acute medical wards. J Hosp Infect 1998;39:213-19.
59. Casewell MW. New threats to the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 1995;30 (Suppl.):465-71.
60. Cookson BD. Methicillin-resistant Staphylococcus aureus in the community: New battlefronts, or are the battles lost? Infect Control Hosp Epidemiol 2000;21:398-403.
61. Aly R, Maibach HI, Shinefield HR, Mandel A, Strauss WG. Bacterial interference among strains of Staphylococcus aureus in man. J Infect Dis 1974;129:720-4.
62. Uehara Y, Nakama H, Agematsu K, Uchida M, Kawakami Y, Abdul F, et al. Bacterial interference among nasal inhabitants: Eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp. J Hosp Infect 2000;44:127-33.
63. Parsons HM. What happened at Hawthorne? Science 1974;183:922-32.
64. Sterne JA, Davey Smith G. Sifting the evidence - What's wrong with significance tests? BMJ 2001;322:226-31.
65. Selvin S. Statistical Analysis of Epidemiological Data. Oxford: Oxford University Press; 1996. Ch. 6.
66. Ihaka R, Gentleman R. R: A language for data analysis and graphics. J Comput Graph Stat 1996;5:299-314.
67. Becker NG. Analysis of Infectious Disease Data. London: Champman and Hall; 1989.
68. Starr JM, Campbell A. Mathematical modeling of Clostridium difficile infection. Clin Microbiol Infect 2001;7:432-7.
69. Cooper BS. The transmission dynamics of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in hospital wards. Coventry: University of Warwick; 2000.
70. Merrer J, Santoli F, Appere De Vecchi C, Tran B, De Jonghe B, Outin H. Colonization pressure' and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000;21:718-23.
71. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, Van Voorhis J, Nathan C, et al. The role of 'colonization pressure' in the spread of vancomycin-resistant enterococci: An important infection control variable. Arch Intern Med 1998;158:1127-32.
72. Lopez-Lozano JM, Monnet DL, Yague A, Burgos A, Gonzalo N, Campillos P, et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: A time series analysis. Int J Antimicrob Agents 2000;14:21-31.
73. The Cochrane Effective Practice and Organisation of Care (EPOC) Review Group. Cochrane Library Database 2000.
74. University Minnesota. Supercomputing Institute. Data Thief II 2002. www.nikhef.nl/~keeshu/datathief/index.html
75. Stone SP, Beric V, Quick A, Balestrini AA, Kibbler CC. The effect of an enhanced infection-control policy on the incidence of Clostridium difficile infection and methicillin-resistant Staphylococcus aureus colonization in acute elderly medical patients. Age Ageing 1998;27:561-8.
76. Faoagali JL, Thong ML, Grant D. Ten years' experience with methicillin-resistant Staphylococcus aureus in a large Australian hospital. J Hosp Infect 1992;20:113-19.
77. Brady LM, Thomson M, Palmer MA, Harkness JL. Successful control of endemic MRSA in a cardiothoracic surgical unit. Med J Aust 1990;152:240-5.
78. Souweine B, Traore O, Aublet-Cuvelier B, Bret L, Sirot J, Laveran H, et al. Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients. J Hosp Infect 2000;45:107-16.
79. Arnow P, Allyn PA, Nichols EM, Hill DL, Pezzlo M, Bartlett RH. Control of methicillin-resistant Staphylococcus aureus in a burn unit: Role of nurse staffing. J Trauma 1982;22:954-9.
80. Pittet D, Hugonnet S, Harbath S, Mourouga P, Sauvan V, Touveneau S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000;356:1307-12.
81. Blumberg LH, Klugman KP. Control of methicillin-resistant Staphylococcus aureus bacteraemia in high-risk areas. Eur J Clin Microbiol Infect Dis 1994;13:82-5.
82. Selkon JB, Stokes ER, Ingham HR. The role of an isolation unit in the control of hospital infection with methicillin-resistant staphylococci. J Hosp Infect 1980;1:41-6.
83. Murray-Leisure KA, Geib S, Graceley D, Rubin-Slutsky AB, Saxena N, Muller HA, et al. Control of epidemic methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1990;11:343-50.
84. Cosseron-Zerbib M, Roque Afonso AM, Naas T, Durand P, Meyer L, Costa Y, et al. A controll programme for MRSA (methicillin-resistant Staphylococcus aureus) containment in a paediatric intensive care unit: Evaluation and impact on infections caused by other micro-organisms. J Hosp Infect 1998;40:225-35.
85. Campbell JR, Zaccaria E, Mason EO Jr, Baker CJ. Epidemiological analysis defining concurrent outbreaks of Serratia marcescens and methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit. Infect Control Hosp Epidemiol 1998;19:924-8.
86. Farrington M, Trundle C, Redpath C, Anderson L. Effects on nursing workload of different methicillin-resistant Staphylococcus aureusi (MRSA) control strategies. J Hosp Infect 2000;46:118-22.
87. El Hagrasy M. An outbreak of methicillin-resistant Staphylococcus aureus (MRSA) in a hospital in the UAE: Problems and solutions. Emirates Med J 1997;15:17-21.
88. Cox RA, Conquest C, Mallaghan C, Marples RR. A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J Hosp Infect 1995;29:87-106.
89. Duckworth GJ, Lothian JL, Williams JD. Methicillin-resistant Staphylococcus aureus: Report of an outbreak in a London teaching hospital. J Hosp Infect 1988;11:1-15.
90. Tambic A, Power EG, Tambic T, Snur I, French GL. Epidemiological analysis of methicillin-resistant Staphylococcus aureus in a Zagreb Trauma Hospital using a randomly amplified polymorphic DNA-typing method. Eur J Clin Microbiol & Infect Dis 1999;18:335-40.
91. Farrington M, Redpath C, Trundle C, Coombert S, Brown NM. Winning the battle but losing the war: Methicillin-resistant Staphylococcus aureus (MRSA) infection at a teaching hospital. QJM 1998;91:539-48.
92. Harbarth S, Martin Y, Rohner P, Henry N, Auckenthaler R, Pittet D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000;46:43-9.
93. Girou E, Azar J, Wolkenstein P, Cizeau F, Brun-Buisson C, Roujeau JC. Comparison of systematic versus selective screening for methicillin-resistant Staphylococcus aureus carriage in a high-risk dermatology ward. Infect Control Hosp Epidemiol 2000;21:583-7.
94. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998;27:543-50.
95. Jernigan JA, Titus MG, Groschel DH, Getchell-White S, Farr BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996;143:496-504.
96. Linnemann CC, Jr., Mason M, Moore P, Korfhagen TR, Staneck JL. Methicillin-resistant Staphylococcus aureus: Experience in a general hospital over four years. Am J Epidemiol 1982;115:941-50.
97. Kac G, Buu-Hoi A, Herisson E, Biancardini P, Debure C. Methicillin-resistant Staphylococcus aureus. Nosocomial acquisition and carrier state in a wound care center. Arch Dermatol 2000;136:735-9.
98. Pearman JW, Christiansen KJ, Annear DI, Goodwin CS, Metcalf C, Donovan FP, et al. Control of methicillin-resistant Staphylococcus aureus (MRSA) in an Australian metropolitan teaching hospital complex. Med J Aust 1985;142:103-8.
99. Alvarez S, Shell C, Gage K, Guarderas J, Kasprzyk D, Besing J, et al. An outbreak of methicillin-resistant Staphylococcus aureus eradicated from a large teaching hospital. Am J Infect Control 1985;13:115-21.
100. Ward TT, Winn RE, Hartstein AI, Sewell DL. Observations relating to an inter-hospital outbreak of methicillin-resistant Staphylococcus aureus: Role of antimicrobial therapy in infection control. Infect Control 1981;2:453-9.
101. Oto MA, Pinto CME, Martinez CV, Fabio BC, Soza MA, Jerez RA, et al. Control of methicillin resistant Staphylococcus aureus at a neonatal ward. Rev Chil Pediatr 1992;63:134-8.
102. Talon D, Rouget C, Cailleaux V, Bailly P, Thouverez M, Barale F, et al. Nasal carriage of Staphylococcus aureus and cross-contamination in a surgical intensive care unit: Efficacy of mupirocin ointment. J Hosp Infect 1995;30:39-49.
103. Jones MR, Martin DR. Outbreak of methicillin-resistant Staphylococcus aureus infection in a New Zealand hospital. N Z Med J 1987;100:369-73.
104. Lugeon C, Blanc DS, Wenger A, Francioli P. Molecular epidemiology of methicillin-resistant Staphylococcus aureus at a low-incidence hospital over a 4-year period. Infect Control Hosp Epidemiol 1995;16:260-7.
105. Schlünzen L, Lund B, Schouenborg P, Skov RL. Outbreak of methicillin resistant Staphylococcus aureus in a central hospital. Ugeskr Laeger 1997;159:431-5.
106. Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: Is it cost effective? Infect Control Hosp Epidemiol 1999;20:473-7.
107. Barakate MS, Harris JP, West RH, Vickery AM, Sharp CA, Macleod C, et al. A prospective survey of current methicillin-resistant Staphylococcus aureus control measures. Aust N Z J Surg 1999;69:712-16.
108. Hartstein AI, LeMonte AM, Iwamoto PK. DNA typing and control of methicillin-resistant Staphylococcus aureus at two affiliated hospitals. Infect Control Hosp Epidemiol 1997;18:42-8.
109. Esveld MI, De Boer AS, Notenboom AJ, Van Pelt W, Van Leeuwen WJ. Secondary infection with methicillin resistant Staphylococcus aureus in Dutch hospitals July 1994-June 1996. Ned Tijdschr Geneeskd 1999;143:205-8.
110. Ribner BS, Landry MN, Gholson GL. Strict versus modified isolation for prevention of nosocomial transmission of methicillin-resistant Staphylococcus aureus. Infect Control 1986;7:317-20.
111. Shanson DC, Johnstone D, Midgley J. Control of a hospital outbreak of methicillin-resistant Staphylococcus aureus infections: Value of an isolation unit. J Hosp Infect 1985;6:285-92.
112. Pfaller MA, Wakefield DS, Hollis R, Frederickson M, Evans E, Massanari RM. The clinical microbiology laboratory as an aid in infection control. The application of molecular techniques in epidemiologic studies of methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 1991;14:209-17.
113. Back NA, Linnemann CC Jr, Staneck JL, Kotagal UR. Control of methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit: Use of intensive microbiologic surveillance and mupirocin. Infect Control Hosp Epidemiol 1996;17:227-31.
114. Yano M, Doki Y, Inoue M, Tsujinaka T, Shiozaki H, Monden M. Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery. Surg Today 2000;30:16-21.
115. Law MR, Gill ON, Turner A. Methicillin-resistant Staphylococcus aureus: Associated morbidity and effectiveness of control measures. Epidemiol Infect 1988;101:301-9.
116. Ayliffe GA, Lilly HA, Lowbury EJ. Decline of the hospital Staphylococcus? Incidence of multiresistant Staph. aureus in three Birmingham hospitals. Lancet 1979;i:538-41.
117. Hall LE, Klein EG, Slater LN. A descriptive analysis of methicillin resistant Staphylococcus aureus in veterans. Am J Infect Control 1998;16:89 (abstract).
118. Coello R, Jimenez J, Garcia M, Arroyo P, Minguez D, Fernandez C, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 1994;13:74-81.
119. Mayall B, Martin R, Keenan AM, Irving L, Leeson P, Lamb K. Blanket use of intranasal mupirocin for outbreak control and long-term prophylaxis of endemic methicillin-resistant Staphylococcus aureus in an open ward. J Hosp Infect 1996;32:257-66.
120. Barakate MS, Yang YX, Foo SH, Vickery AM, Sharp CA, Fowler LD, et al. An epidemiological survey of methicillin-resistant Staphylococcus aureus in a tertiary referral hospital. J Hosp Infect 2000;44:19-26.
121. Austin DJ, Bonten MJ, Weinstein RA, Slaughter S, Anderson RM. Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci USA 1999;96:6908-13.
122. Austin DJ, Anderson RM. Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales. J Infect Dis 1999;179:883-91.
123. Lipsitch M, Bergstrom CT, Levin BR. The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions. Proc Natl Acad Sci USA 2000;97:1938-43.
124. Sebille V, Chevret S, Valleron AJ. Modeling the spread of resistant nosocomial pathogens in an intensive-care unit. Infect Control Hosp Epidemiol 1997;18:55-92.
125. Grundmann H, Hori S, Winter B, Tami A, Austin DJ. Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: Fitting a model to the data. J Infect Dis 2002;185:481-8.
126. Jernigan JA, Clemence MA, Stott GA, Titus MG, Alexander CH, Palumbo, et al. Control of methicillin-resistant Staphylococcus aureus at a university hospital: One decade later. Infect Control Hosp Epidemiol 1995;16:686-96.
127. MacKinnon MM, Allen KD. Long-term MRSA carriage in hospital patients. J Hosp Infect 2000;46:216-21.
128. Beaujean DJ, Weersink AJ, Blok HE, Frenay HM, Verhoef J. Determining risk factors for methicillin-resistant Staphylococcus aureus carriage after discharge from hospital. J Hosp Infect 1999;42:213-18.
129. Scanvic A, Denic L, Gaillon S, Giry P, Andremont A, Lucet JC. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001;32:1393-8.
130. Sanford MD, Widmer AF, Bale MJ, Jones RN, Wenzel RP. Efficient detection and long-term persistent of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1994;19:1123-8.
131. Fitzpatrick F, Murphy OM, Brady A, Prout S, Fenelon LE. A purpose built MRSA cohort unit. J Hosp Infect 2000;46:271-9.
132. Abudu L, Blair I, Fraise A, Cheng KK. Methicillin-resistant Staphylococcus aureus (MRSA): A community-based prevalence survey. Epidemiol Infect 2001;126:351-6.
133. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
134. Richet H, Wiesel M, Le Gallou F, André-Richet B, Espaze E. Methicillin-resistant Staphylococcus aureus control in hospitals: The French experience. Association des Pays de la Loire pour l'Eviction des Infections Nosocomiales. Infect Control Hosp Epidemiol 1996;17:509-11.
135. Trilla A, Marco F, Moreno AV, Prat A, Vila J, Bayas JM, et al. Prevention and control of methicillin-resistant Staphylococcus aureus nosocomial infection in Barcelona (Spain). Chemotherapy 1996;42 (Suppl 2):53-9.
136. Struelens MJ, Ronveaux O, Jans B, Mertens R. Methicillin-resistant Staphylococcus aureus epidemiology and control in Belgian hospitals, 1991 to 1995. Groupement pour le Dépistage, l'Etude et la Prévention des Infections Hospitalières. Infect Control Hosp Epidemiol 1996;17:503-8.
137. Schmitz FJ, MacKenzie CR, Geisel R, Wagner S, Idel H, Verhoef J, et al. Methicillin resistant Staphylococcus aureus strains in the greater Dusseldorf area. Eur J Epidemiol 1997;13:709-17.
138. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-60.
139. Cameron CA, Trivedi PK. Regression Analysis of Count Data. 1st ed. Cambridge: Cambridge University Press; 1998.
140. Pittet D, Safran E, Harbath S, Borst F, Copin P, Rohner P, et al. Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance and control: Role of a hospital information system. Infect Control Hosp Epidemiol 1996;17:496-502.
141. Britton A, McKee M, Black N, McPherson K, Sanderson C, Bain C. Choosing between randomised and non-randomised studies: A systematic review. Health Technol Assess 1998;2:1-124.
142. Egger M, Davey Smith G, Altman D. Systematic Reviews in Health Care: Meta-Analysis in Context. London: BMJ Books; 2002.
143. Grimes DA, Schulz KF. Cohort studies: Marching towards outcomes. Lancet 2002;359:341-5.
144. Grimes DA, Schulz KF. Descriptive studies: What they can and cannot do. Lancet 2002;359:145-9.
145. Hayes RJ, Alexander ND, Bennett S, Cousens SN. Design and analysis issues in cluster-randomized trials of interventions against infectious diseases. Stat Methods Med Res 2000;9:95-116.
146. Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: At what costs? Infect Control Hosp Epidemiol 1999;20:408-11.
147. Adeyemi-Doro FA, Scheel O, Lyon DJ, Cheng AF. Living with methicillin-resistant Staphylococcus aureus: A 7-year experience with endemic MRSA in a university hospital. Infect Control Hosp Epidemiol 1997;18:765-7.
148. Aihara M, Sakai M, Iwasaki M, Shimakawa K, Kozaki S, Kubo M, et al. Prevention and control of nosocomial infection caused by methicillin-resistant Staphylococcus aureus in a premature infant ward - Preventive effect of a povidone-iodine wipe of neonatal skin. Postgrad Med J 1993;69 (Suppl 3): S117-21.
149. Allen KD, Ridgway EJ, Parsons LA. Hexachlorophane powder and neonatal staphylococcal infection. J Hosp Infect 1994;27:29-33.
150. Ang SW, Lee ST. The pattern of burn infection in the Singapore National Burns Centre. Ann Acad Med Singapore 1997;26:599-603.
151. Asensio A, Guerrero A, Quereda C, Lizan M, Martinez-Ferrer M. Colonization and infection with methicillin-resistant Staphylococcus aureus: Associated factors and eradication. Infect Control Hosp Epidemiol 1996;17:20-8.
152. Aubry-Damon H, Legrand P, Brun-Buisson C, Astier A, Soussy CJ, Leclercq R. Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: Roles of an infection control program and changes in aminoglycoside use. Clin Infect Dis 1997;25:647-53.
153. Bacon AE, Jorgensen KA, Wilson KH, Kauffman CA. Emergence of nosocomial methicillin-resistant Staphylococcus aureus and therapy of colonized personnel during a hospital-wide outbreak. Infect Control 1987;8:145-50.
154. Bailly P, Mulin B, Minary P, Talon D. Control of methicillin-resistant Staphylococcus aureus infections in a university hospital: Critical analysis of results. Med Mal Infect 1999;29:178-83.
155. Barrett FF, McGehee RF, Jr., Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med 1968;279:441-8.
156. Barrett SP, Gill ON, Mellor JA, Bryant JC. A descriptive survey of uncontrolled methicillin-resistant Staphylococcus aureus in a twin site general hospital. Postgrad Med J 1988;64:606-9.
157. Barrett SP. The value of nasal mupirocin in containing an outbreak of methicillin-resistant staphylococcus aureus in an orthopaedic unit. J Hosp Infect 1990;15:137-42.
158. Barrett SP, Teare EL, Sage R. Methicillin resistant Staphylococcus aureus in three adjacent health districts of south-east England 1986-91. J Hosp Infect 1993;24:313-25.
159. Bartzokas CA, Paton JH, Gibson MF, Graham F, McLoughlin GA, Croton RS, et al. Control and eradication of methicillin-resistant Staphylococcus aureus on a surgical unit. N Engl J Med 1985;311:1422-5.
160. Bitar CM, Mayhall CG, Lamb VA, Bradshaw TJ, Spadora AC, Dalton HP. Outbreak due to methicillin- and rifampin-resistant Staphylococcus aureus: Epidemiology and eradication of the resistant strain from the hospital. Infect Control 1987;8:15-23.
161. Bock BV, Pasiecznik K, Meyer RD. Clinical and laboratory studies of nosocomial Staphylococcus aureus resistant to methicillin and aminoglycosides. Infect Control 1982;3:224-8.
162. Bouchard O, Bosseray A, Queyrel V, Gavazzi G, Croize J, Leclercq P, et al. Experience with an isolation unit for patients infected with multiresistant bacteria: Retrospective study of 49 patients. Presse Med 1999;28:1405-8.
163. Boyce JM, Landry M, Deetz TR, DuPont HL. Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections. Infect Control 1981;2:110-16.
164. Boyce JM, White RL, Causey WA, Lockwood WR. Burn units as a source of methicillin-resistant Staphylococcus aureus infections. JAMA 1983;249:2803-7.
165. Boyce JM, Opal SM, Potter BG, Medeiros AA. Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis. Clin Infect Dis 1993;17:496-504.
166. Bradley JM, Noone P, Townsend DE, Grubb WB. Methicillin-resistant Staphylococcus aureus in a London hospital. Lancet 1985;i:1493-5.
167. Brun Buisson BC, Rauss A, Legrand P, Mentec H, Ossart M, Eb F, et al. Mupirocin treatment of S. aureus nasal carriage and prevention of infection in intensive care units: A multicenter controlled study. Med Mal Infect 1994;24:1229-39.
168. Campins M, Almar J, Rodriguez V, Jasa A, Ruiz MA, Gasser I. Newborn unit methicillin-resistant Staphylococcus aureus outbreak: Efficacy of infection
169. Cohen SH, Morita MM, Bradford M. A seven-year experience with methicillin-resistant Staphylococcus aureus. Am J Med 1991;91(3B):233S-237S.
170. Coovadia YM, Bhana RH, Johnson AP, Haffejee I, Marples RR. A laboratory-confirmed outbreak of rifampicin-methicillin resistant Staphylococcus aureus (RMRSA) in a newborn nursery. J Hosp Infect 1989:14:303-12.
171. Craven DE, Reed C, Kollisch N, DeMaria A, Lichtenberg D, Shen McCabe WR. A large outbreak of infections caused by a strain of Staphylococcus aureus resistant to oxacillin and aminoglycosides. Am J Med 1981;71:53-8.
172. Dacre J, Emmerson AM, Jenner EA. Gentamicin-methicillin-resistant Staphylococcus aureus: Epidemiology and containment of an outbreak. J Hosp Infect 1986;7:130-6.
173. Dancer SJ, Crawford A. Keeping MRSA out of a district general hospital. J Hosp Infect 1999;43 Suppl:S19-27.
174. Danchivijitr S, Chantrasakul C, Chokloikaew S, Trakoolsomboon S. An outbreak of methicillin-resistant Staphylococcus aureus (M.R.S.A.) in a burn unit. J Med Assoc Thailand 1995;78 (Suppl. 1): S11-14.
175. Darouiche R, Wright C, Hamill R, Koza M, Lewis D, Markowski J. Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin. Antimicrob Agents Chemother 1991;35:1612-15.
176. Davies EA, Emmerson AM, Hogg GM, Patterson ME, Shields MD. An outbreak of infection with a methicillin-resistant Staphylococcus aureus in a special care baby unit: Value of topical mupirocin and of traditional methods of infection control. J Hosp Infect 1987;10:120-8.
177. Dickson D, Czurylo K. The nursing management of an MRSA outbreak in an acute care facility. Nurs Manage 1988;19:22-4.
178. Dunkle LM, Naqvi SH, McCallum R, Lofgren JP. Eradication of epidemic methicillin-gentamicin-resistant Staphylococcus aureus in an intensive care nursery. Am J Med 1981;70:455-8.
179. Dziekan G, Hahn A, Thune K, Schwarzer G, Schafer K, Daschner FD, et al. Methicillin-resistant Staphylococcus aureus in a teaching hospital: Investigation of nosocomial transmission using a matched case-control study. J Hosp Infect 2000;46:263-70.
180. Fang FC, McClelland M, Guiney DG, Jackson MM, Hartstein AI, Morthland VH, et al. Value of molecular epidemiologic analysis in a nosocomial methicillin-resistant Staphylococcus aureus outbreak. JAMA 1993;270:1323-8.
181. Farrington M, Ling J, Ling T, French GL. Outbreaks of infection with methicillin-resistant Staphylococcus aureus on neonatal and burns units of a new hospital. Epidemiol Infect 1990;105:215-28.
182. Fazal BA, Telzak EE, Blum S, Turett GS, Petersen-Fitzpatrick FE, Lorian V. Trends in the prevalence of methicillin-resistant Staphylococcus aureus associated with discontinuation of an isolation policy. Infect Control Hosp Epidemiol 1996;17:372-4.
183. Finkelstein R, Markel A, Reinherz G, Hashman N, Merzbach D. The emergence of methicillin-resistant Staphylococcus aureus infections in an Israeli hospital. J Hosp Infect 1989;14: 55-61.
184. Forward KR, Arbique JC. Cumulative yield from patient surveillance cultures for methicillin-resistant Staphylococcus aureus during a hospital outbreak. Infect Control Hosp Epidemiol 1997;18:776-8.
185. Fukatsu K, Saito H, Matsuda T, Ikeda S, Furukawa S, Muto T. Influences of type and duration of antimicrobial prophylaxis on an outbreak of methicillin-resistant Staphylococcus aureus and on the incidence of wound infection. Arch Surg 1997;132:1320-5.
186. Geldner G, Ruoff M, Hoffmann HJ, Kiefer P, Georgieff M, Wiedeck H. Cost analysis concerning MRSA-infection in ICU. Anasthesiol Intensivmed Notfallmed Schmerzther 1999;34:409-13.
187. Gerken MV. An outbreak of methicillin-resistant Staphylococcus aureus in a large medical center. Am Surg 1983;49:179-81.
188. Gilmore DS, Montgomerie JZ, Graham IE. Category 1, 2, 3 and 4: A procedure-oriented isolation system. Infect Control 1986;7:263-7.
189. Goetz AM, Muder RR. The problem of methicillin-resistant Staphylococcus aureus: A critical appraisal of the efficacy of infection control procedures with a suggested approach for infection control programs. Am J Infect Control 1992;20:80-4.
190. Goetz MB, Mulligan ME, Kwok R, O'Brien H, Caballes C, Garcia JP. Management and epidemiologic analyses of an outbreak due to methicillin-resistant Staphylococcus aureus. Am J Med 1992;92:607-14.
191. Gonzalez M, Elias M, Matute B, Garcia I, Calaf A. Follow-up and monitoring of MRSA after eradication of an outbreak of nosocomial infection. Enferm Clin 1996;6:82-5.
192. Guiguet M, Rekacewicz C, Leclercq B, Brun Y, Escudier B, Adremont A. Effectiveness of simple measures to control an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections in an intensive care unit. Infect Control Hosp Epidemiol 1990;11:23-6.
193. Haddad Q, Sobayo EI, Basit OBA, Rotimi VO. Outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. J Hosp Infect 1993;23:211-22.
194. Haiduven-Griffiths D. Outbreak of methicillin-resistant Staphylococcus aureus on a surgical service. Am J Infect Control 1988;16:123-7.
195. Haley RW, Cushion NB, Tenover FC, Bannerman TL, Dryer D, Ross J, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995;171:614-24.
196. Hansen B, Pedersen LN, Arpi M, Obel N. Incidence of methicillin-resistant Staphylococcus aureus among Kosovar-Albanian refugees at the refugee-centre in Randers. Ugeskr Laeger 2000;162:6241-3.
197. Hartstein AI, Denny MA, Morthland VH, LeMonte AM, Pfaller MA. Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit. Infect Control Hosp Epidemiol 1995;16:405-11.
198. Hiramatsu N, Hashimoto S, Fujita N, Kageyama K, Ashida H, Kimura A, et al. The influence of the use of mupirocin nasal ointment on the incidence of endogenous MRSA infections in an intensive care unit. Masui 2000;49:867-71.
199. Hitomi S, Kubota M, Mori N, Baba S, Yano H, Okuzumi K, et al. Control of a methicillin-resistant staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. J Hosp Infect 2000;46:123-9.
200. Ibelings MM, Bruining HA. Methicillin-resistant Staphylococcus aureus: Acquisition and risk of death in patients in the intensive care unit. Eur J Surg 1998;164:411-18.
201. Irish D, Eltringham I, Teall A, Pickett H, Farelly H, Reith S, et al. Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin. J Hosp Infect 1998;39:19-26.
202. Jones JW, Carter A, Ewings P, O'Boyle PJ. An MRSA outbreak in a urology ward and its association with Nd:YAG coagulation laser treatment of the prostate. J Hosp Infect 1999;41:39-44.
203. Kahla Clemenceau CN, Barre E, Prat H, Thibault M, Bourret C, Richardin F, et al. Methicillin-resistant Staphylococcus aureus outbreak in a general hospital intensive care unit. Pathol Biol 1999;47:449-56.
204. King K, Brady L, Thomson M, Harkness JL. Antibiotic-resistant staphylococci in a teaching hospital. Med J Aust 1982;2:461-5.
205. Kouda M, Nakayama H, Hashimoto D, Haraguchi Y, Kaziwara S, Utoh H, et al. Analysis of measure for prevention of nosocomial infection by MRSA in Tokyo Metropolitan Police Hospital. Jpn Pharmacol Ther 1992;20:295-305.
206. Kumari DN, Haji TC, Keer V, Hawkey PM, Duncanson V, Flower E. Ventilation grilles as a potential source of methicillin-resistant Staphylococcus aureus causing an outbreak in an orthopaedic ward at a distinct general hospital. J Hosp Infect 1998;39:127-33.
207. Kusachi S, Sumiyama Y, Nagao J, Kawai K, Arima Y, Yoshida Y, et al. New methods of control against postoperative methicillin-resistant Staphylococcus aureus infection. Surg Today 1999;29:724-9.
208. Lejeune B, Buzit-Losquin F, Simitzis-Le Flohic AM, Le Bras MP, Alix D. Outbreak of gentamicin-methicillin-resistant Staphylococcus aureus infection in an intensive care unit for children. J Hosp Infect 1986;7:21-5.
209. Lepelletier D, Regnier B, Richet H. Control of infections caused by multidrug resistant organisms in French hospitals. Example of methicillin-resistant Staphylococcus aureus. Med Mal Infect 1997;27:165-71.
210. Lessing MP, Jordens JZ, Bowler IC. When should healthcare workers be screened for methicillin-resistant Staphylococcus aureus? J Hosp Infect 1996;34:205-10.
211. Lingnau W, Allerberger F. Control of an outbreak of methicillin-resistant Staphylococcus aureus (MRSA) by hygienic measures in a general intensive care unit. Infection 1994;22 (Suppl 2): S135-9.
212. Linnemann CC, Jr., Moore P, Staneck JL, Pfaller MA. Reemergence of epidemic methicillin-resistant Staphylococcus aureus in a general hospital associated with changing staphylococcal strains. Am J Med 1991;91(3B):238S-244S.
213. Liu CC, Hor LI, Wu YH, Huang AH, Lin CH, Chuang YC. Investigation and elimination of epidemic methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Chung-Hua Min Kuo Hsiao Erh Ko i Hsueh Hui Tsa Chih 1993;34:285-93.
214. Locksley RM, Cohen ML, Quinn TC, Tompkins LS, Coyle MB, Kirihara JM, Counts GW. Multiply antibiotic-resistant Staphylococcus aureus: Introduction, transmission, and evolution of nosocomial infection. Ann Intern Med 1982;97:317-24.
215. Loulergue J, Audurier A, DeLarbre JM, De Gialluly C. Changes in microbial ecology and use of cloxacillin. J Hosp Infect 1994;27:275-83.
216. Maeder K, Ginunas VJ, Montgomerie JZ, Canawati HN. Methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with spinal cord injury. Paraplegia 1993;31:639-44.
217. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory. Med J Australia 1996;164:721-3.
218. Matsumura H, Yoshizawa N, Narumi A, Harunari N, Sugamata A, Watanabe, et al. Effective control of methicillin-resistant Staphylococcus aureus in a burn unit. Burns 1996;22:283-6.
219. Mehtar S, Drabu YJ, Mayet F. Expenses incurred during a 5-week epidemic methicillin-resistant Staphylococcus aureus outbreak. J Hosp Infect 1989;13:199-200.
220. Mehtar S. The continuing problem of 'hospital staphylococci': Why? J Chemother 1994;6 (Suppl 4): 25-31.
221. Mehtar S. Infection control programmes: Are they cost-effective? J Hosp Infect 1995;30 (Suppl.)26-34.
222. Melo Cristino JA, Pereira AT, Afonso F, Naidoo JN. Methicillin-resistant Staphylococcus aureus: A 6-month survey in a Lisbon paediatric hospital. J Hyg 1986;97:265-72.
223. Meier PA, Carter CD, Wallace SE, Hollis RJ, Pfaller MA, Herwaldt LA. A prolonged outbreak of methicillin-resistant Staphylococcus aureus in the burn unit of a tertiary medical center. Infect Control Hosp Epidemiol 1996;17:798-802.
224. Michault A, Simac C. Hospital antibiotic resistance from 1993 to 1997 in Reunion. Med Mal Infect 1999;29:451-61.
225. Michel MF, Priem CC. Control at hospital level of infections by methicillin-resistant staphylococci in children. J Hyg 1971;69:453-60.
226. Millar MR, Keyworth N, Lincoln C, King B, Congdon O. 'Methicillin-resistant' Staphylococcus aureus in a regional neonatology unit. J Hosp Infect 1987;10:187-97.
227. Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996;17:811-13.
228. Mochizuki H, Sugiyama M. Prevention and treatment of MRSA infection in emergency surgical ward. Nippon Geka Gakkai Zasshi 1992;93:902-5.
229. Moore EP, Williams EW. A maternity hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect 1991;19:5-16.
230. Morgan MG, Harte-Barry MJ. Methicillin-resistant Staphylococcus aureus: A ten-year survey in a Dublin hospital. J Hosp Infect 1989;14:357-62.
231. Morrison L, Stolarek I. Does MRSA affect patient outcomes in the elderly? A retrospective pilot study. J Hosp Infect 2000;45:169-71.
232. Mulhern B, Griffin E. An epidemic of gentamicin/cloxacillin resistant staphylococcal infection in a neonatal unit. Ir Med J 1981;74:228-9.
233. Murphy S, Denman S, Bennett RG, Greenough WB III, Lindsay J, Zelesnick LB. Methicillin-resistant Staphylococcus aureus colonization in a long-term-care facility. J Am Geriatr Soc 1992;40:213-17.
234. Nettleman MD, Trilla A, Fredrickson M, Pfaller M. Assigning responsibility: Using feedback to achieve sustained control of methicillin-resistant Staphylococcus aureus. Am J Med 1991;91(3B): 228S-232S.
235. Netto Dos Santos KR, De Souza FL, Gontijo Filho PP. Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals. Infect Control Hosp Epidemiol 1996;17:813-16.
236. Ng SP, Gomez JM, Lim SH, Ho NK. Reduction of nosocomial infection in a neonatal intensive care unit (NICU). Singapore Med J 1998;39:319-23.
237. Nicolle LE, Dyck B, Thompson G, Roman S, Kabani A, Plourde P, et al. Regional dissemination and control of epidemic methicillin-resistant Staphylococcus aureus. Manitoba Chapter of CHICA - Canada. Infect Control Hosp Epidemiol 1999;20:202-5.
238. Nørregaard C, Jensen I, Olesen J, Hagedorn S. Spread and control of methicillin resistant Staphylococcus aureus in a department of dermatology. Ugeskr Laeger 1998;160:2257-60.
239. Okano M, Noguchi S, Tabata K, Matsumoto Y. Topical gentian violet for cutaneous infection and nasal carriage with MRSA. Int J Dermatol 2000;39:942-4.
240. Olona CM, Tico FN, Ramirez GL, Del Valle OO, Castello VT, Garcia FL. Methicillin-resistant Staphylococcus aureus: A four-year experience in a spinal cord injury unit in Spain. Spinal Cord 1996;34:315-19.
241. Osono E, Takahashi M, Kurihara S, Ohwada K, Sakurai Y, Onoda N, et al. Effects of 'isolating hemodialysis' on prevention of methicillin-resistant Staphylococcus aureus cross-infection in a hemodialysis unit. Clin Nephrol 2000;54:128-33.
242. Park C, Pearce J. A major outbreak of methicillin resistant Staphylococcus aureus among patients and staff at Johannesburg Hospital during 1986-1987. Nurs RSA 1989;4:37-9.
243. Peacock JE, Wenzel RP. Methicillin resistent Staph. aureus (MRSA): Introduction and spread within a hospital. Clin Res 1979;27:787A.
244. Pick FCM, Rose M, Wang D, Gardner BP, Gillett AP. The prevention of spread of methicillin resistant Staphylococcus aureus in a spinal injuries centre. Paraplegia 1994;32:732-5.
245. Prieto J, Clark J. Infection control. Dazed and confused. Nurs Times 1999;95(28):49-50.
246. Rahman M. Epidemic methicillin-resistant Staphylococcus aureus (EMRSA): Experience from a health district of central England over five years. Postgrad Med J 1993;69 Suppl 3:S126-9.
247. Rahman M, Sanderson PJ, Bentley AH, Barrett SP, Karim QN, Teare EL, et al. Control of MRSA. J Hosp Infect 2000;44:151-3.
248. Reardon CM, Brown TP, Stephenson AJ, Freedlander E. Methicillin-resistant Staphylococcus aureus in burns patients - Why all the fuss? Burns 1998;24:393-7.
249. Reboli AC, John JF Jr, Levkoff AH. Epidemic methicillin-gentamicin-resistant Staphylococcus aureus in a neonatal intensive care unit. Am J Dis Child 1989;143:34-9.
250. Reboli AC, John JF Jr, Platt CG, Cantey JR. Methicillin-resistant Staphylococcus aureus outbreak at a Veterans' Affairs Medical Center: Importance of carriage of the organism by hospital personnel. Infect Control Hosp Epidemiol 1990;11:291-6.
251. Ransjö U, Malm M, Hambraeus A, Artursson G, Hedlund A. Methicillin-resistant Staphylococcus aureus in two burn units: Clinical significance and epidemiological control. J Hosp Infect 1989;13:355-65.
252. Rhinehart E, Shlaes DM, Keys TF, Serkey J, Kirkley B, Kim C, et al. Nosocomial clonal dissemination of methicillin-resistant Staphylococcus aureus. Elucidation by plasmid analysis. Arch Intern Med 1987;147:521-4.
253. Ribner BS, Landry MN, Kidd K, Peninger M, Riddick J. Outbreak of multiply resistant Staphylococcus aureus in a pediatric intensive care unit after consolidation with a surgical intensive care unit. Am J Infect Control 1989;17:244-9.
254. Ridley M, Lynn R, Barrie D, Stead KC. Antibiotic-resistant Staphylococcus aureus and hospital antibiotic policies. Lancet 1970;i:230-3.
255. Roberts RB, Tennenberg AM, Eisner W, Hargrave J, Drusin LM, Yurt R, et al. Outbreak in a New York City teaching hospital burn center caused by the Iberian epidemic clone of MRSA. Microb Drug Resist 1998;4:175-83.
256. Rodriguez G, Gaspar MC, Mariano A, Fernandez C, Sanchez P, Fereres J. Management of an outbreak of methicillin-resistant Staphylococcus aureus in a risk area with empirical intranasal mupirocin. J Hosp Infect 1997;36:155-7.
257. Roman RS, Smith J, Walker M, Byrne S, Ramotar K, Dyck B, et al. Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain. Clin Infect Dis 1997;25:698-705.
258. Romance L, Nicolle L, Ross J, Law B. An outbreak of methicillin-resistant Staphylococcus aureus in a pediatric hospital - How it got away and how we caught it. Can J Infect Control 1991;6:11-13.
259. Rosenfeld CR, Laptook AR, Jeffery J. Limited effectiveness of triple dye in preventing colonization with methicillin-resistant Staphylococcus aureus in a special care nursery. Pediatr Infect Dis J 1990;9:290-1.
260. Rountree PM, Beard MA. Hospital strains of Staphylococcus aureus, with particular reference to methicillin-resistant strains. Med J Aust 1968;2:1163-8.
261. Ruchel R, Mergeryan H, Boger O, Langefeld C, Witte W. Outbreak of methicillin-resistant Staphylococcus aureus in a German tertiary-care hospital. Infect Control Hosp Epidemiol 1999;20:353-5.
262. Rumbak MJ, Cancio MR. Significant reduction in methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia associated with the institution of a prevention protocol. Crit Care Med 1995;23:1200-3.
263. Sáez-Llorens X, Castrejon-De-Wong MM, Castano E, De Suman O, De Moros D, De Atencio I. Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: A lesson from a pediatric institution in a developing country. Pediatr Infect Dis J 2000;19:200-6.
264. Santos KR, Teixeira LM, Bravo Neto GP, Fonseca LS, Gontijo Filho PP. Mupirocin- and methicillin-resistant Staphylococcus aureus spreading in an intermediate-care unit in a Brazilian hospital. Infect Control Hosp Epidemiol 1998;19:622-3.
265. Saroglou G, Cromer M, Bisno AL. Methicillin-resistant Staphylococcus aureus: Interstate spread of nosocomial infections with emergence of gentamicin-methicillin resistant strains. Infect Control 1980;1:81-9.
266. Saravolatz LD, Pohlod DJ, Arking LM. Community-acquired methicillin-resistant Staphylococcus aureus infections: A new source for nosocomial outbreaks. Ann Intern Med 1982;97:325-9.
267. Schmitz FJ, Verhoef J, Idel H, Hadding H, Heinz HP, Jones ME. Impact of hygienic measures on the development of methicillin resistance among staphylococci between 1991 and 1996 in a university hospital. J Hosp Infect 1998;38:237-40.
268. Schwarzkopf A, Karch H. A two-level isolation system for the defence against nosocomial infections with oxacillin-resistant Staphylococcus aureus and other multi-resistant pathogens. Hyg Med 1994;19:595-601.
269. Schweitzer M, Walther T, Juraske J, Osswald PM. Infection control measures in intensive-care-medicine. Efficacy of intranasal mupirocin in the prevention and therapy of an MRSA outbreak. Intensivmed Notf Med 1997;34:778-89.
270. Scott GM, Thomson R, Malone-Lee J, Ridgway GL. Cross-infection between animals and man: Possible feline transmission of Staphylococcus aureus infection in humans? J Hosp Infect 1988;12:29-34.
271. Scudeller L, Leoncini O, Boni S, Navarra A, Rezzani A, Verdirosi S, et al. MRSA carriage: The relationship between community and healthcare setting. A study in an Italian hospital. J Hosp Infect 2000;46:222-9.
272. Seipp HM, Stroh A. Multiresistant Staphylococcus aureus (MRSA) - Significantly reduced incidence and rate in a tertiary care hospital, 1994 to 1999. Hyg Med 1999;24:224-37.
273. Sheridan RL, Weber J, Benjamin J, Pasternack MS, Tompkins RG. Control of methicillin-resistant Staphylococcus aureus in a pediatric burn unit. Am J Infect Control 1994;22:340-5.
274. Shimada M, Kamakura T, Itasaka H, Matsumata T, Hashizume M, Sugimachi K. The significance of methicillin-resistant Staphylococcus aureus infection in general surgery: A multivariate analysis of risk factors and preventive approaches. Surg Today 1993;23:880-4.
275. Sloot N, Walz G, Burzyk U, Fritsche D. Increased occurrence of MRSA outbreaks. Kranenh-Arzt 1997;4:144-7.
276. Sloot N, Siebert J, Hoffler U. Eradication of MRSA from carriers by means of whole-body washing with antiseptic in combination with mupirocin nasal ointment. Zentralbl Hyg Umweltmed 1999;202:513-23.
277. Smith NP, Nelson MR, Azadian B, Gazzard BG. An outbreak of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-seropositive persons. Int J STD AIDS 1998;9:726-30.
278. Snyder LL, Wiebelhaus P, Boon SE, Morin RA, Goering R. Methicillin resistant Staphylococcus aureus eradication in a burn center. J Burn Care Rehabil 1993;14 (2 II Suppl):164-8.
279. Pavillard R, Harvey K, Douglas D, Hewstone A, Andrew J, Collopy B, et al. Epidemic of hospital-acquired infection due to methicillin-resistant Staphylococcus aureus in major Victorian hospitals. Med J Aust 1982;1:451-4.
280. Spicer WJ. Three strategies in the control of staphylococci including methicillin-resistant Staphylococcus aureus. J Hosp Infect 1985;5 Suppl A: 45-9.
281. Stover BH, Duff A, Adams G, Buck G, Hancock G, Rabalais G. Emergence and control of methicillin-resistant Staphylococcus aureus in a children's hospital and pediatric long-term care facility. Am J Infect Control 1992;20:248-55.
282. Stubbs S, Scott G, Gillbe C. Admission screening policy for MRSA: Who needs it? Who does not? J Cardiothorac Anesth 1990;4(6 Suppl 3):65.
283. Suh K, Toye B, Jessamine P, Chan F, Ramotar K. Epidemiology of methicillin-resistant Staphylococcus aureus in three Canadian tertiary-care centers. Infect Control Hosp Epidemiol 1998;19:395-400.
284. Suh HK, Jeon YH, Song JS, Hwang SJ, Cheong HJ. A molecular epidemiologic study of methicillin-resistant Staphylococcus aureus infection in patients undergoing middle ear surgery. Eur Arch Otorhinolaryngol 1998;255:347-51.
285. Swanston WH. Methicillin resistant Staphylococcus aureus. West Indian Med J 1999;48:20-2.
286. Szromba C, Bowman-Riney S. Successful intervention in the reduction of methicillin resistant Staphylococcus aureus (MRSA) catheter related bacteremia. ANNA Journal 1992,19:153.
287. Takesue Y, Yokoyama T, Kodama T, Fujimoto M, Okita M, Sewake H, et al. Methicillin-resistant Staphylococcus aureus in nosocomial infections in the surgical ward and operating room. Hiroshima J Med Sci 1989;38:183-6.
288. Tambic A, Power EG, Talsania H, Anthony RM, French GL. Analysis of an outbreak of non-phagetypeable methicillin-resistant Staphylococcus aureus by using a randomly amplified polymorphic DNA assay. J Clin Microbiol 1997;35:3092-7.
289. Tan KW, Tay L, Lim SH. An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit in Singapore: A 20-month study of clinical characteristics and control. Singapore Med J 1994;35:277-82.
290. Thom JD, Wolfe V, Perkash I, Lin VW. Methicillin-resistant Staphylococcus aureus in patients with spinal cord injury. J Spinal Cord Med 1999,22:125-31.
291. Tuffnell DJ, Croton RS, Hemingway DM, Hartley MN, Wake PN, Garvey PJ. Methicillin resistant Staphylococcus aureus; The role of antisepsis in the control of an outbreak J Hosp Infect 1987;10:255-9.
292. Turner GC, Cox PE. Resistance to cloxacillin among hospital staphylococci. J Clin Pathol 1967;20:870-4.
293. Tyzack R. The management of methicillin-resistant Staphylococcus aureus in a major hospital. J Hosp Infect 1985;6 Suppl A:195-9.
294. Uetera Y, Matsumine T, Awane Y, Yamazaki E, Yokota T. Investigation of an outbreak of nosocomial infection due to methicillin-resistant Staphylococcus aureus (MRSA) in the surgical ward of Tokyo Metropolitan Fuchu Hospital. J Infect Chemother 1999;5:75-81.
295. Van Rijn RR, Kuijper EC, Kreis RW. Seven-year experience with a 'quarantine and isolation unit' for patients with burns. A retrospective analysis. Burns 1997;23:345-8.
296. Vandenbroucke-Grauls CM, Frenay HME, Van Klingern B, Savelkoul TF, Verhoef J. Control of epidemic methicillin-resistant Staphylococcus aureus in a Dutch University Hospital. Eur J Clin Microbiol Infect Dis 1991;10:6-11.
297. Frenay HME, Vandenbroucke-Grauls CMJE, Savelkoul TJF, Rommes JH, Van Klingeren B, Verhoef J. Spread and control of a methicillin-resistant Staphylococcus aureus in a university hospital. Ned Tijdschr Geneeskd 1990;134:1169-73.
298. Valls V, Gomez HP, Gonzalez PR, Cuadros JA, Romanyk JP, Ena J. Long-term efficacy of a program to control methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994;13:90-5.
299. Vandenbroucke-Grauls CM. Methicillin-resistant Staphylococcus aureus control in hospitals: The Dutch experience. Infect Control Hosp Epidemiol 1996;17:512-13.
300. Walsh TJ, Vlahov D, Hansen SL, Sonnenberg E, Khabbaz R, Gadacz T, et al. Prospective microbiologic surveillance in control of nosocomial methicillin-resistant Staphylococcus aureus. Infect Control 1987;8:7-14.
301. Webster J, Faoagali JL. An in-use comparison of chlorhexidine gluconate 4% w/v, glycol-poly-siloxane plus methylcellulose and a liquid soap in a special care baby unit. J Hosp Infect 1989;14:141-51.
302. Webster J, Faoagali JL. Endemic methicillin-resistant Staphylococcus aureus in a special care baby unit: A 2 year review. J Paediatr Child Health 1990;26:160-3.
303. Webster J. Handwashing in a neonatal intensive care nursery: Product acceptability and effectiveness of chlorhexidine gluconate 4% and triclosan 1%. J Hosp Infect 1992;21:137-41.
304. Webster J, Faoagali JL, Cartwright D. Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan. J Paediatr Child Health 1994;30:59-64.
305. Wilcox MH, Fitzgerald P, Freeman J, Denton M, Gill AB, Hoy C, et al. A five year outbreak of methicillin-susceptible Staphylococcus aureus phage type 53,85 in a regional neonatal unit. Epidemiol Infect 2000;124:37-45.
306. Wilson P, Dunn LJ. Using an MRSA isolation scoring system to decide whether patients should be nursed in isolation. Hyg Med 1996;21:465-77.
307. Witte W, Braulke C, Heuck D, Cuny C. Analysis of nosocomial outbreaks with multiply and methicillin-resistant Staphylococcus aureus (MRSA) in Germany: Implications for hospital hygiene. Infection 1994;22 Suppl 2:S128-34.
308. Zafar AB, Butler RC, Reese DJ, Gaydos LA, Mennonna PA. Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 1995;23:200-8.
309. Center for Disease Control. Outline for Surveillance and Control of Nosocomial Infection. Atlanta, GA: Center for Disease Control; 1976.
310. Cruse PJ, Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980;60:27-40.
311. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128-40.
312. Werkgroep Infecie Preventie. Management Policy for Methicillin-Resistant Staphylococcus Aureus. Guideline No. 35A. Leiden: WIP; 1994.
313. Steering Group of the Second National Prevalence Survey. National prevalence survey of hospital acquired infections: Definitions. A preliminary report of the Steering Group of the Second National Prevalence Survey. J Hosp Infect 1993;24:69-76.
314. Center for Disease Control. Guidelines for isolation precautions in hospital. Infect Control 1983;4 (Suppl):245-325.
315. Dixon RE, Brachman PS, Bennett JV. Isolation Techniques for Use in Hospitals. 2nd ed. Atlanta, GA: Government Printing Office, Centers for Disease Control; 1975.
316. Garner JS, Bennett JV, Schenkler WE. Surveillance of nosocomial infections. In Proceedings of the International Conference on Nosocomial Infections. Centers for Disease Control, Chicago, 1970. Chicago, IL: American Hospital Association; 1971. pp. 277-81.
317. Lynch P, Jackson MM, Cummings MJ, Stamm WE. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann Intern Med 1987;107:243-6.
318. Health Commission Victoria. Staphylococcal Infections in Hospitals. 2nd ed. Health Commission Victoria, Australia; 1981.
319. Renshaw R. Modelling biological populations in space and time. Cambridge Studies in Mathematical Biology. Cambridge: Cambridge University Press; 1993.
320. Cookson BD. Nosocomial antimicrobial resistance surveillance. J Hosp Infect 1999;43:S97-103.